Aldeyra Therapeutics Statistics
Total Valuation
ALDX has a market cap or net worth of $226.96 million. The enterprise value is $109.58 million.
| Market Cap | 226.96M |
| Enterprise Value | 109.58M |
Important Dates
The next estimated earnings date is Thursday, August 1, 2024, before market open.
| Earnings Date | Aug 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ALDX has 59.41 million shares outstanding. The number of shares has increased by 1.06% in one year.
| Shares Outstanding | 59.41M |
| Shares Change (YoY) | +1.06% |
| Shares Change (QoQ) | +0.37% |
| Owned by Insiders (%) | 2.49% |
| Owned by Institutions (%) | 61.39% |
| Float | 43.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.00 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.50, with a Debt / Equity ratio of 0.14.
| Current Ratio | 6.50 |
| Quick Ratio | n/a |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.44 |
Financial Efficiency
Return on equity (ROE) is -24.70% and return on invested capital (ROIC) is -27.41%.
| Return on Equity (ROE) | -24.70% |
| Return on Assets (ROA) | -20.30% |
| Return on Capital (ROIC) | -27.41% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.00M |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.78% in the last 52 weeks. The beta is 1.45, so ALDX's price volatility has been higher than the market average.
| Beta (5Y) | 1.45 |
| 52-Week Price Change | -52.78% |
| 50-Day Moving Average | 3.74 |
| 200-Day Moving Average | 3.43 |
| Relative Strength Index (RSI) | 54.18 |
| Average Volume (20 Days) | 373,871 |
Short Selling Information
The latest short interest is 2.54 million, so 4.28% of the outstanding shares have been sold short.
| Short Interest | 2.54M |
| Short Previous Month | 2.43M |
| Short % of Shares Out | 4.28% |
| Short % of Float | 5.89% |
| Short Ratio (days to cover) | 6.52 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -35.38M |
| Pretax Income | -30.01M |
| Net Income | -30.01M |
| EBITDA | -27.67M |
| EBIT | -27.93M |
| Earnings Per Share (EPS) | -$0.51 |
Balance Sheet
The company has $133.04 million in cash and $15.66 million in debt, giving a net cash position of $117.38 million or $1.98 per share.
| Cash & Cash Equivalents | 133.04M |
| Total Debt | 15.66M |
| Net Cash | 117.38M |
| Net Cash Per Share | $1.98 |
| Equity (Book Value) | 113.42M |
| Book Value Per Share | 1.91 |
| Working Capital | 119.17M |
Cash Flow
| Operating Cash Flow | -30.85M |
| Capital Expenditures | n/a |
| Free Cash Flow | -30.85M |
| FCF Per Share | -$0.52 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ALDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.06% |
| Shareholder Yield | -1.06% |
| Earnings Yield | -13.22% |
| FCF Yield | -13.59% |
Analyst Forecast
The average price target for ALDX is $9.33, which is 144.24% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.33 |
| Price Target Difference | 144.24% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |